C. Tournemine

552 total citations
15 papers, 287 citations indexed

About

C. Tournemine is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, C. Tournemine has authored 15 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Molecular Biology. Recurrent topics in C. Tournemine's work include Estrogen and related hormone effects (7 papers), Hormonal and reproductive studies (4 papers) and Reproductive System and Pregnancy (3 papers). C. Tournemine is often cited by papers focused on Estrogen and related hormone effects (7 papers), Hormonal and reproductive studies (4 papers) and Reproductive System and Pregnancy (3 papers). C. Tournemine collaborates with scholars based in France. C. Tournemine's co-authors include D. Philibert, Jean‐Pierre Raynaud, M. Moguilewsky, Jean Fiet, Georges Teutsch, M.M. Bouton, R. Deraedt, Jean Jacques, F. Nique and A. Bèlanger and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Investigative Dermatology and Molecular Pharmacology.

In The Last Decade

C. Tournemine

15 papers receiving 228 citations

Peers

C. Tournemine
B. Valcaccia United Kingdom
W.H. Pearlman United States
Elizabeth K. Symes United Kingdom
Philip A. Bell United Kingdom
B. Valcaccia United Kingdom
C. Tournemine
Citations per year, relative to C. Tournemine C. Tournemine (= 1×) peers B. Valcaccia

Countries citing papers authored by C. Tournemine

Since Specialization
Citations

This map shows the geographic impact of C. Tournemine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Tournemine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Tournemine more than expected).

Fields of papers citing papers by C. Tournemine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Tournemine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Tournemine. The network helps show where C. Tournemine may publish in the future.

Co-authorship network of co-authors of C. Tournemine

This figure shows the co-authorship network connecting the top 25 collaborators of C. Tournemine. A scholar is included among the top collaborators of C. Tournemine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Tournemine. C. Tournemine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Philibert, D., et al.. (1989). New analogues of mifepristone with more dissociated antiprogesterone activities. Journal of Steroid Biochemistry. 34(1-6). 413–417. 18 indexed citations
2.
Moguilewsky, M. & C. Tournemine. (1988). The Antiandrogen Anandron Potentiates the Castrating Effect of the LH-RH Agonist Buserelin in the Rat. American Journal of Clinical Oncology. 11. S148–151. 5 indexed citations
3.
Moguilewsky, M., et al.. (1987). What is an antiandrogen and what is the physiological and pharmacological rationale for combined "castration" + "antiandrogen" therapy.. PubMed. 243A. 315–40. 12 indexed citations
4.
Tournemine, C., et al.. (1987). Pharmacological activity of four metabolites of anandronR. European Journal of Cancer and Clinical Oncology. 23(8). 1250–1250. 3 indexed citations
5.
Secchi, Jean, Dominique Lecaque, C. Tournemine, & D. Philibert. (1987). Early glycogenesis in the uterine glandular cells of the rabbit induced by progestins: a quantitative investigation. Cell and Tissue Research. 248(2). 359–64. 1 indexed citations
6.
Moguilewsky, M., Jean Fiet, C. Tournemine, & Jean‐Pierre Raynaud. (1986). Pharmacology of an antiandrogen, anandron, used as an adjuvant therapy in the treatment of prostate cancer. Journal of Steroid Biochemistry. 24(1). 139–146. 48 indexed citations
7.
Bouton, M.M., Dominique Lecaque, Jean Secchi, & C. Tournemine. (1986). Effect of a New Topically Active Antiandrogen (RU38882) on the Rat Sebaceous Gland: Comparison with Cyproterone Acetate. Journal of Investigative Dermatology. 86(2). 163–167. 12 indexed citations
8.
Jacques, Jean, et al.. (1985). Antiandrogenic activity of a series of des-A-steroid derivatives. Journal of Medicinal Chemistry. 28(12). 1796–1803. 27 indexed citations
9.
Raynaud, Jean‐Pierre, M. Moguilewsky, C. Tournemine, et al.. (1985). Pharmacology and clinical studies with RU 23908 (Anandron).. PubMed. 185A. 99–120. 12 indexed citations
10.
Moguilewsky, M., C. Tournemine, & D. Philibert. (1983). 456 Dynamics of the receptor interactions of danazol and gestrinone in the rat. Correlation with biological activities. Journal of Steroid Biochemistry. 19. 156–156. 3 indexed citations
11.
Canceill, Josette, et al.. (1983). Substituted derivatives of a-nor-5α-androstane and a-nor-5α-estrane—structure and affinity for hormonal receptors. Journal of Steroid Biochemistry. 18(6). 643–647. 2 indexed citations
12.
Teutsch, Georges, D. Philibert, C. Tournemine, & A. Bèlanger. (1982). Synthesis of 11β-vinyl-19-norsteroids as potent progestins. Steroids. 39(6). 607–615. 13 indexed citations
13.
Hardy, M P, et al.. (1982). 198. 7α-Alkyl steroidal spirolactones as potent aldosterone antagonists. Journal of Steroid Biochemistry. 17(3). lxvi–lxvi. 11 indexed citations
14.
Philibert, D., et al.. (1982). 204. RU 38486 — A potent antiprogesterone. Journal of Steroid Biochemistry. 17(3). lxviii–lxviii. 23 indexed citations
15.
Raynaud, Jean‐Pierre, et al.. (1973). Comparative Study of Estrogen Action. Molecular Pharmacology. 9(4). 520–533. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026